Current Health manufacturers a wireless remote patient monitoring device that continuously assesses patients’ vital signs. Using AI, the wearable extracts proactive insights about the user’s health trajectory and delivers this information to clinicians to encourage earlier intervention.
The wearable is already in use in the post-acute setting at various National Health Service facilities in the U.K., where clinicians review the device’s recommendations in an effort to reduce readmissions for patients whose conditions deteriorate after hospital discharge.
Mount Sinai Brooklyn in New York City also has begun using the wearable, according to the company.
“Current’s continuous and proactive monitoring platform has the potential to alert us to patient deterioration faster and give our team data insights they can act on earlier,” Scott Lorin, MD, president of Mount Sinai Brooklyn, said in a news release.
More articles on supply chain:
Facebook to help connect hospitals to blood donors
FDA commissioner suggests blockchain technology to improve drug traceability
An injection for a blood clotting disorder, a rival Botox treatment & more: 4 recent FDA approvals
